Pancreatic Cancer Research

ResearcherChinese PLA General HospitalNo recent work listed

Xin Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9588-0164; OpenAlex author ID A5100363101. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
26
Papers, trials and grants by year

2015: 1 paper · 2016: 2 papers · 2017: 1 paper · 2018: 3 papers

Papers 7

  1. Activation of Nrf2 by Sulforaphane Inhibits High Glucose-Induced Progression of Pancreatic Cancer via AMPK Dependent Signaling. Co-author DOI 10.1159/000494547↗
  2. Inhibiting YAP expression suppresses pancreatic cancer progression by disrupting tumor-stromal interactions. Co-author DOI 10.1186/s13046-018-0740-4↗
  3. RETRACTED: GATA4 inhibits cell differentiation and proliferation in pancreatic cancer. Co-author DOI 10.1371/journal.pone.0202449↗
  4. Lipoxin A4 reverses mesenchymal phenotypes to attenuate invasion and metastasis via the inhibition of autocrine TGF-β1 signaling in pancreatic cancer. Co-author DOI 10.1186/s13046-017-0655-5↗
  5. Lipoxin A4 Attenuates Cell Invasion by Inhibiting ROS/ERK/MMP Pathway in Pancreatic Cancer. Co-author DOI 10.1155/2016/6815727↗
  6. YAP Inhibition by Resveratrol via Activation of AMPK Enhances the Sensitivity of Pancreatic Cancer Cells to Gemcitabine. First author DOI 10.3390/nu8100546↗
  7. Ginkgolic acid suppresses the development of pancreatic cancer by inhibiting pathways driving lipogenesis. Co-author DOI 10.18632/oncotarget.3663↗

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wanxing Duan · 6 shared papers, 2015–2018 · strength 0.36
  2. Qingyong Ma · 5 shared papers, 2016–2018 · strength 0.31
  3. Zhengdong Jiang · 5 shared papers, 2015–2018 · strength 0.30
  4. Jiguang Ma · 5 shared papers, 2015–2018 · strength 0.30
  5. Zheng Wang · 5 shared papers, 2015–2018 · strength 0.30
  6. Xuqi Li · 5 shared papers, 2015–2018 · strength 0.30
  7. Cancan Zhou · 4 shared papers, 2016–2018 · strength 0.26
  8. Jianjun Lei · 4 shared papers, 2015–2018 · strength 0.22
  9. Qinhong Xu · 4 shared papers, 2015–2018 · strength 0.22
  10. Liang Zong · 3 shared papers, 2016–2018 · strength 0.18
  11. Ke Chen · 3 shared papers, 2016–2018 · strength 0.18
  12. Liankang Sun · 2 shared papers, 2016–2017 · strength 0.11
  13. Yan Gong · 1 shared paper, 2018 · strength 0.10
  14. Qiang Zeng · 1 shared paper, 2018 · strength 0.10
  15. Liang Cheng · 1 shared paper, 2018 · strength 0.07
  16. Bin Yan · 1 shared paper, 2018 · strength 0.07
  17. Liang Han · 1 shared paper, 2017 · strength 0.06
  18. Wei Li · 1 shared paper, 2016 · strength 0.05
  19. Tao Shan · 1 shared paper, 2016 · strength 0.05
  20. Hao Sun · 1 shared paper, 2016 · strength 0.05
  21. Lun Zhang · 1 shared paper, 2016 · strength 0.05
  22. Xiongwei Huo · 1 shared paper, 2015 · strength 0.04
  23. Liang Han · 1 shared paper, 2015 · strength 0.04
  24. Ligang Nan · 1 shared paper, 2015 · strength 0.04
  25. Erxi Wu · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.